Dr Lalchand. Lab — 360° view

Dr Lalchand. Lab, a company in the Healthcare Service Provider industry, reported revenue of ₹2.13 crore and a net loss of ₹0.13 crore for the March 2026 quarter.

Dr Lalchand. Lab (BSE: DLCL) closed at ₹6.48 on 20 Nov 2026, down 56.7% over the past year. Its market capitalisation is ₹6 crore and it trades at 93.3 times earnings.

Share price
₹6.48 (20 Nov 2026)
Market cap
₹6 Cr (20 Nov 2026)
P/E
93.35 (20 Nov 2026)
Revenue
₹2 Cr (March 2026 quarter)
Net profit
₹-0 Cr (March 2026 quarter)
ROCE
0.79% (FY26)
ROE
0.50% (FY26)
Book value
₹16.4 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹17.99 / ₹5.81 (20 Nov 2026)
1-year return
-56.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: DLCL

Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.